NCT00960310 Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fed Conditions Status COMPLETED Phase PHASE1
NCT00960245 Relative Bioavailability Study of Nadolol (1 x 80 mg) Tablets Under Fasting Conditions Status COMPLETED Phase PHASE1
NCT00959933 Relative Bioavailability Study of Ribavirin 200 Capsules and Rebetol 200 mg Capsules in Females Under Non-Fasting Conditions Status COMPLETED Phase PHASE1
NCT00959439 Relative Bioavailability Study of Naproxen Delayed-Release Tablets (375 mg) Status COMPLETED Phase PHASE1
NCT00959335 Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting Conditions Status COMPLETED Phase PHASE1
NCT00947128 To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Non-Fasting Conditions Status COMPLETED Phase PHASE1
NCT00947076 To Demonstrate the Relative Bioavailability of Fluoxetine Hydrochloride Capsules, 40 mg Status COMPLETED Phase PHASE1
NCT00947063 To Demonstrate the Relative Bioavailability Study of Promethazine HCl 50 mg Tablets Under Fasting Conditions Status COMPLETED Phase PHASE1
NCT00947024 To Demonstrate the Effect of Food on the Bioavailability of Glipizide Status COMPLETED Phase PHASE1
NCT00946790 To Demonstrate the Relative Bioavailability of Hydroxychloroquine Sulfate, 200 mg Tablets Status COMPLETED Phase PHASE1
NCT00946764 To Demonstrate the Relative Bioavailability of Sandoz Inc. and Tyco Healthcare (Tofranil) 50 mg Imipramine Hydrochloride Tablets In Healthy Adults Volunteers Under Fasting Conditions Status COMPLETED Phase PHASE1
NCT00946751 To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions Status COMPLETED Phase PHASE1
NCT00946725 To Demonstrate the Relative Bioavailability of Atenolol Tablets, 100 mg Status COMPLETED Phase PHASE1
NCT00946686 To Demonstrate the Relative Bioavailability, Parallel Study Of Leflunomide 20 mg Tablets Under Fasting Conditions Status COMPLETED Phase PHASE1
NCT00946621 To Demonstrate the Relative Bioavailability Study of Ramipril 10 mg Capsules Under Non-Fasting Conditions Status COMPLETED Phase PHASE1
NCT00946608 To Demonstrate the Relative Bioavailability Study of Loratadine 10 mg Tablets Status COMPLETED Phase PHASE1
NCT00946504 To Demonstrate the Relative Bioequivalency Comparing Geneva's 10 mg Glipizide Tablets To Roerig's 10 mg Glucotrol Tablets Status COMPLETED Phase PHASE1
NCT00946491 To Demonstrate the Relative Bioequivalency of Generic Haloperidol Tablets Versus Haldol in Normal Volunteers Status COMPLETED Phase PHASE1
NCT00946465 To Demonstrate the Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fasting Conditions Status COMPLETED Phase PHASE1
NCT00946387 To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Fasting Conditions Status COMPLETED Phase PHASE1